YU10403A - Kompleksi koji sadrže perfluoralkile sa ostacima šećera, postupci za njihovo dobijanje i njihova primena - Google Patents

Kompleksi koji sadrže perfluoralkile sa ostacima šećera, postupci za njihovo dobijanje i njihova primena

Info

Publication number
YU10403A
YU10403A YU10403A YUP10403A YU10403A YU 10403 A YU10403 A YU 10403A YU 10403 A YU10403 A YU 10403A YU P10403 A YUP10403 A YU P10403A YU 10403 A YU10403 A YU 10403A
Authority
YU
Yugoslavia
Prior art keywords
perfluoroalkyl
sugar residues
producing
containing complexes
same
Prior art date
Application number
YU10403A
Other languages
English (en)
Inventor
Johannes Platzek
Peter Mareski
Ulrich Niedballa
Bernd Raduchel
Hanns-Joachim Weinmann
Bernd Misselwitz
Original Assignee
Schering Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Aktiengesellschaft filed Critical Schering Aktiengesellschaft
Publication of YU10403A publication Critical patent/YU10403A/sh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02Acyclic radicals, not substituted by cyclic structures
    • C07H15/04Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/26Acyclic or carbocyclic radicals, substituted by hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H23/00Compounds containing boron, silicon, or a metal, e.g. chelates, vitamin B12

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Kompleksi koji sadrže perfluoralkile sa ostacima šećera opšte formule I u kojoj R predstavlja preko 1-OH ili 1-SH pozicije vezani mono- ili oligosaharidni ostatak Rf znači perfluorisani ugljenični lanac K je metalni kompleks, a Y i Z predstavljaju linker grupe su podesni u intravenoznoj limfografiji, za tumor-dijagnostiku i za vizuelizaciju infarkta i nekroze.[The invention relates to perfluoroalkyl-containing complexes comprising sugar residues of the general formula (I), wherein R represents a mono- or oligosaccharide residue bound in the 1-OH or 1-SH position, Rf represents a perfluorated carbon chain, K is a metal complex and Y and Z are linker groups. The inventive complexes are suitable for use in intravenous lymphography, in tumor diagnosis and for infarct and necrosis imaging.
YU10403A 2000-08-11 2001-07-23 Kompleksi koji sadrže perfluoralkile sa ostacima šećera, postupci za njihovo dobijanje i njihova primena YU10403A (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10040381A DE10040381C1 (de) 2000-08-11 2000-08-11 Perfluoralkylhaltige Komplexe mit Zuckerresten, Verfahren zu deren Herstellung und ihre Verwendung

Publications (1)

Publication Number Publication Date
YU10403A true YU10403A (sh) 2006-05-25

Family

ID=7652861

Family Applications (1)

Application Number Title Priority Date Filing Date
YU10403A YU10403A (sh) 2000-08-11 2001-07-23 Kompleksi koji sadrže perfluoralkile sa ostacima šećera, postupci za njihovo dobijanje i njihova primena

Country Status (31)

Country Link
EP (1) EP1307446B1 (sh)
JP (1) JP2004506631A (sh)
KR (1) KR100820387B1 (sh)
CN (1) CN1249058C (sh)
AR (1) AR035579A1 (sh)
AT (1) ATE293623T1 (sh)
AU (2) AU8972901A (sh)
BG (1) BG107540A (sh)
BR (1) BR0113192A (sh)
CA (1) CA2418790A1 (sh)
CZ (1) CZ2003340A3 (sh)
DE (2) DE10040381C1 (sh)
DK (1) DK1307446T3 (sh)
EE (1) EE200300059A (sh)
ES (1) ES2240517T3 (sh)
HK (1) HK1062016A1 (sh)
HR (1) HRP20030172A2 (sh)
HU (1) HUP0300744A3 (sh)
IL (1) IL154328A0 (sh)
MX (1) MXPA03001285A (sh)
NO (1) NO20030648L (sh)
NZ (1) NZ524079A (sh)
PL (1) PL360359A1 (sh)
PT (1) PT1307446E (sh)
RU (1) RU2280644C2 (sh)
SK (1) SK1542003A3 (sh)
TW (1) TWI243170B (sh)
UA (1) UA75364C2 (sh)
WO (1) WO2002014309A1 (sh)
YU (1) YU10403A (sh)
ZA (1) ZA200301948B (sh)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19948651B4 (de) * 1999-09-29 2006-10-05 Schering Ag Para- und diamagnetische perfluorhaltige Verbindungen enthaltende galenische Formulierungen, deren Herstellung und Verwendung
US7344704B2 (en) 2002-07-10 2008-03-18 Schering Ag Use of perfluoroalkyl-containing metal complexes as contrast media in MR-imaging for visualization of intravascular thrombi
DE10231799B4 (de) * 2002-07-10 2006-10-05 Schering Ag Verwendung von perfluoralkylhaltigen Metallkomplexen als Kontrastmittel im MR-Imaging zur Darstellung von Intravasalen Thromben
DE10260372B4 (de) 2002-12-13 2007-01-04 Schering Ag Kernspintomographievorrichtung und Verfahren zur ortsaufgelösten Bilddarstellung
EP1904462A2 (de) * 2005-07-15 2008-04-02 Bayer Schering Pharma Aktiengesellschaft Perfluoralkylhaltige komplexe, verfahren zu deren herstellung, sowie deren verwendung
DE102006049821A1 (de) 2006-10-18 2008-04-24 Bayer Schering Pharma Aktiengesellschaft Metallchelate mit perfluoriertem PEG-Rest, Verfahren zu deren Herstellung, sowie deren Verwendung
JP2010507645A (ja) * 2006-10-25 2010-03-11 コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ 前立腺癌を検出するための造影剤
DE102008024976A1 (de) 2008-05-23 2009-12-17 Marvis Technologies Gmbh Medizinisches Instrument
JP2011190183A (ja) * 2010-03-11 2011-09-29 Noguchi Institute フルオラス化糖結合型クラウンエーテル誘導体
EP2450067A1 (en) 2010-10-18 2012-05-09 MaRVis Technologies GmbH Medical device
EP2484388A1 (en) 2011-02-05 2012-08-08 MaRVis Technologies GmbH Implantable or insertable MRI-detectable medical device having a coating comprising paramagnetic ions and a process for preparing it
EP2692365A1 (en) 2012-08-03 2014-02-05 MaRVis Medical GmbH Implantable or insertable MRI-detectable medical device having a coating comprising paramagnetic ions and a process for preparing it
EP3101012A1 (en) 2015-06-04 2016-12-07 Bayer Pharma Aktiengesellschaft New gadolinium chelate compounds for use in magnetic resonance imaging
CN110035996B (zh) 2016-11-28 2022-08-09 拜耳医药股份公司 用于磁共振成像的新型高弛豫性钆螯合物
KR20210095168A (ko) 2018-11-23 2021-07-30 바이엘 악티엔게젤샤프트 조영 매체의 제형 및 그의 제조 방법

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5707604A (en) * 1986-11-18 1998-01-13 Access Pharmaceuticals, Inc. Vivo agents comprising metal-ion chelates with acidic saccharides and glycosaminoglycans, giving improved site-selective localization, uptake mechanism, sensitivity and kinetic-spatial profiles
AU623901B2 (en) * 1988-01-26 1992-05-28 Nycomed As Paramagnetic compounds comprising chelating moiety, linker group macro molecule and paramagnetic metal
ES2116291T3 (es) * 1989-10-23 1998-07-16 Nycomed Salutar Inc Agentes quelantes de metales en sitios multiples.
US5330743A (en) * 1992-11-12 1994-07-19 Magnetic Research, Inc. Aminosaccharide contrast agents for magnetic resonance images
CA2160819A1 (en) * 1994-10-21 1996-04-22 Yuji Hashiguchi Diagnostic imaging agent
DE19603033A1 (de) * 1996-01-19 1997-07-24 Schering Ag Perfluoralkylhaltige Metallkomplexe, Verfahren zu deren Herstellung und ihre Verwendung in der NMR-Diagnostik
DE19728954C1 (de) * 1997-06-30 1999-04-22 Schering Ag Saccharid-Konjugate, diese enthaltende pharmazeutische Mittel, Verfahren zu ihrer Herstellung und ihre Verwendung
DE19729013A1 (de) * 1997-07-03 1999-02-04 Schering Ag Oligomere, perfluoralkylhaltige Verbindungen, Verfahren zu deren Herstellung und ihre Verwendung in der NMR-Diagnostik
DE19744004C1 (de) * 1997-09-26 1999-07-22 Schering Ag Lipophile Metall-Komplexe für Nekrose und Infarkt-Imaging
DE19758105A1 (de) * 1997-12-18 1999-06-24 Schering Ag Dendritische Polymer-Saccharid-Konjugate, diese enthaltende pharmazeutische Mittel, Verfahren zu ihrer Herstellung und ihre Verwendung
DE19914101C1 (de) * 1999-03-22 2000-10-12 Schering Ag Perfluoralkylamide, ihre Herstellung und ihre Verwendung in der Diagnostik
DE19948651B4 (de) * 1999-09-29 2006-10-05 Schering Ag Para- und diamagnetische perfluorhaltige Verbindungen enthaltende galenische Formulierungen, deren Herstellung und Verwendung

Also Published As

Publication number Publication date
IL154328A0 (en) 2003-09-17
SK1542003A3 (en) 2003-10-07
EP1307446B1 (de) 2005-04-20
HUP0300744A2 (hu) 2003-09-29
AR035579A1 (es) 2004-06-16
RU2280644C2 (ru) 2006-07-27
HUP0300744A3 (en) 2009-01-28
EP1307446A1 (de) 2003-05-07
AU2001289729B2 (en) 2006-11-16
DK1307446T3 (da) 2005-08-15
CN1468234A (zh) 2004-01-14
DE50105965D1 (de) 2005-05-25
AU8972901A (en) 2002-02-25
CA2418790A1 (en) 2003-02-07
DE10040381C1 (de) 2002-06-06
PL360359A1 (en) 2004-09-06
JP2004506631A (ja) 2004-03-04
CZ2003340A3 (cs) 2003-09-17
PT1307446E (pt) 2005-08-31
NO20030648D0 (no) 2003-02-10
EE200300059A (et) 2004-12-15
HK1062016A1 (en) 2004-10-15
UA75364C2 (en) 2006-04-17
WO2002014309A1 (de) 2002-02-21
HRP20030172A2 (en) 2005-04-30
ATE293623T1 (de) 2005-05-15
BG107540A (bg) 2003-11-28
MXPA03001285A (es) 2004-05-17
CN1249058C (zh) 2006-04-05
KR20030024855A (ko) 2003-03-26
KR100820387B1 (ko) 2008-04-08
ZA200301948B (en) 2004-06-25
TWI243170B (en) 2005-11-11
ES2240517T3 (es) 2005-10-16
NO20030648L (no) 2003-04-11
NZ524079A (en) 2005-10-28
BR0113192A (pt) 2003-07-15

Similar Documents

Publication Publication Date Title
YU10403A (sh) Kompleksi koji sadrže perfluoralkile sa ostacima šećera, postupci za njihovo dobijanje i njihova primena
WO2002087498A8 (en) Diagnostic imaging compositions, their methods of synthesis and use
MY137552A (en) Methods for treating rheumatic diseases using a soluble ctla4 molecule
RU2010102044A (ru) Конъюгаты, содержащие гидрофильные спейсеры линкеров
AU2003273413A1 (en) Pharmaceutically active oligosaccharide conjugates
WO2007006041A8 (en) Imaging and therapeutic method using monocytes
WO2002088172A3 (en) Pentapeptide compounds and uses related thereto
UA83182C2 (en) Compounds effecting glucokinase
GB2366800A (en) Antibody molecules having specificity for human tumor necrosis factor alpha and use thereof
MXPA05003119A (es) Nuevas imidazopirazinas como inhibidores de cinasas dependientes de ciclinas.
EP1372741A4 (en) MORPHOLINO AND THERAPY IMAGING
EP2147927A3 (en) Use of 131i-tm-601 for the diagnosis and treatment of gliomas
DE50206406D1 (de) Verwendung von heparinoid-derivaten zur behandlung und diagnose von mit heparinoiden behandelbaren erkrankungen
AU1109395A (en) Metal complexes of dendrimeric molecules, diagnostic agents containing them and process for producing the complexes and agents
MXPA03001286A (es) Complejos que contienen perfluoralquilo con radicales polares, metodo para la produccion y el uso de estos.
WO2001051095A3 (de) Paramagnetische dota-derivate, diese enthaltende pharmazeutische mittel, verfahren zu ihrer herstellung und ihre verwendung für das nekrose- und infarkt-mr-imaging
WO2004074454A3 (en) Methods and compositions for the treatment of cancer and infectious disease using alpha (2) macroglobulin-antigenic molecule complexes
WO2002024867A3 (en) Novel compositions and methods for lymphoma and leukemia
WO2003082195A3 (en) Protamine-adenoviral vector complexes and methods of use
WO2002066075A3 (en) Biotin-derivatives and their conjugates with chelating agents
WO2003039484A3 (en) Novel compositions and methods for cancer
WO2005039648A3 (en) Use of metal tricarbonyl complexes as radiotherapeutic chemotoxic agents
WO2002026267A3 (en) Manganes complexes for magnetic resonance imaging
HU9700100D0 (en) Conjugates of metal-komplexes with oligonucleotides, compositions containing them, their radiodiagnostical use and process for producing them
ATE227781T1 (de) Austenitische ni-cr-mo-fe-legierung